ArticleBMJ open2025
Combined effects of visual impairment and chronic kidney disease on all-cause mortality among middle-aged and older adults: a longitudinal, population-based cohort study in China.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveVisual impairment (VI) and chronic kidney disease (CKD) are highly prevalent and associated with increased mortality risk separately. However, their combined effects on mortality risk are not well defined.
designLongitudinal, population-based, cohort study.
settingA nationally representative sample of community-dwelling adults aged 45 and older in China at baseline was recruited from the China Health And Retirement Longitudinal Study (CHARLS).
main outcome measuresAll the participants were classified into four groups based on the presence of CKD and VI. The primary outcome was all-cause mortality. Cox proportional-hazards regression analyses were used to determine the HRs of risk factors.
resultsA total of 15 054 subjects were enrolled. The participants with CKD and VI showed the highest mortality rate (19.22%). The risk of all-cause mortality was significantly greater in participants with CKD and VI (HR: 1.174; 95% CI: 1.055 to 1.293) than in those without CKD or VI, after adjusting for other potential risk factors. Among participants over 70 years old, no significant difference in mortality rate was found among the four groups (all p>0.05).
conclusionsCKD was a significant predictor for all-cause mortality, while VI was not an independent risk factor for long-term survival. Participants with VI and CKD were at an increased risk of all-cause mortality. The effects attenuated with age. Our results may reveal the underlying mechanism behind the VI-CKD-mortality association and reinforce the importance of preventing and treating CKD and VI to avoid premature mortality in middle-aged and older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.